 |
| 07-Mar-13 | Reiterated |
Mizuho |
Neutral |
$45 → $42 |
|
| 25-Jan-13 | Reiterated |
Mizuho |
Neutral |
$41 → $45 |
|
| 26-Oct-12 | Reiterated |
Mizuho |
Neutral |
$39 → $41 |
|
| 22-Oct-12 | Reiterated |
Mizuho |
Neutral |
$33 → $39 |
|
| 06-Aug-12 | Reiterated |
Feltl & Co. |
Hold |
$35.75 → $40 |
|
| 19-Jul-12 | Downgrade |
Feltl & Co. |
Buy → Hold |
$38 → $35.75 |
|
| 27-Apr-12 | Upgrade |
Feltl & Co. |
Hold → Buy |
$38 |
|
| 27-Apr-12 | Reiterated |
Mizuho |
Neutral |
$28 → $32 |
|
| 28-Mar-12 | Downgrade |
Feltl & Co. |
Buy → Hold |
|
|
| 17-Jan-12 | Downgrade |
Feltl & Co. |
Strong Buy → Buy |
$35 → $33.15 |
|
| 20-Dec-11 | Upgrade |
Feltl & Co. |
Buy → Strong Buy |
$39.10 → $35 |
|
| 25-Oct-11 | Downgrade |
Feltl & Co. |
Strong Buy → Buy |
$40.40 → $39.10 |
|
| 30-Jun-11 | Initiated |
Feltl & Co. |
Strong Buy |
$40.40 |
|
| 05-Feb-10 | Upgrade |
Wells Fargo |
Underperform → Market Perform |
|
|
| 05-Jan-10 | Downgrade |
Wells Fargo |
Market Perform → Underperform |
|
|
| 06-Nov-09 | Downgrade |
Jefferies & Co |
Buy → Hold |
$50 → $53 |
|
| 13-Oct-09 | Upgrade |
Credit Suisse |
Neutral → Outperform |
|
|
| 05-Oct-09 | Downgrade |
Canaccord Adams |
Buy → Hold |
$48 |
|
| 10-Aug-09 | Upgrade |
JP Morgan |
Neutral → Overweight |
|
|
| 02-Apr-09 | Upgrade |
Citigroup |
Sell → Buy |
|
|
|
|
| 19-May-13 08:46AM | One Year After The IPO, Is Facebook Already Becoming A New Economy Dog? at Forbes |
| 16-May-13 10:00AM | 4 Stocks Going Ex-Dividend Tomorrow: SLH, STO, RMD, RCL at TheStreet |
| 09:55AM | ResMed Stock To Go Ex-dividend Tomorrow (RMD) at TheStreet |
| 15-May-13 01:03PM | FMS, COO, RMD, THC And HCA, Pushing Health Services Industry Downward at TheStreet |
| 11:30AM | ResMed (RMD) Goes Ex-Dividend Soon at Forbes |
| 10-May-13 09:02AM | X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 17 at Minyanville |
| 09-May-13 01:04AM | Cashed-Up ResMed Mulls $1 Billion Question at The Wall Street Journal |
| 08-May-13 09:59AM | ResMed Stock Hits New 52-Week High (RMD) at TheStreet |
| 07-May-13 01:23PM | New Stock Picks From Navellier & Associates at Seeking Alpha |
| 01:04PM | RESMED INC Financials EDGAR Online Financials |
| 07:40AM | Got Growth? These 5 Stocks Do at Seeking Alpha |
| 06-May-13 03:22PM | 1 Tech, 1 Healthcare And 1 Industrial Goods Company With Recent Intensive Insider Selling at Seeking Alpha |
| 30-Apr-13 11:16PM | RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 29-Apr-13 01:40PM | ResMed's Earnings Beat; Revs Lag Zacks |
| 25-Apr-13 07:40PM | ResMed Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:58PM | ResMed Earnings: Heres Why Investors are Selling Shares Now at Wall St. Cheat Sheet |
| 04:30PM | ResMed Inc. Earnings Call scheduled for 4:30 pm ET today CCBN |
| 04:05PM | ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013 PR Newswire |
| 09:06AM | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and EDGAR Online |
| 08:09AM | ResMed noninvasive ventiliation device cleared by FDA for COPD treatment theflyonthewall.com |
| 08:05AM | InPlay: ResMed Noninvasive ventilation device cleared by FDA for COPD treatment Briefing.com |
| 08:00AM | ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment PR Newswire |
| 07:07AM | Q3 2013 ResMed Inc. Earnings Release - Time Not Supplied CCBN |
| 24-Apr-13 12:07PM | Resmed Earnings Preview: Can This Streak Continue? at Wall St. Cheat Sheet |
| 22-Apr-13 05:00PM | ResMed Inc. (RMD): Today's Featured Health Services Winner at TheStreet |
| 18-Apr-13 04:07PM | ResMed Eyes Continued Growth Despite Medicare Cuts at Investor's Business Daily |
| 17-Apr-13 07:22AM | Money Managers Are Buying 5 Dividend Stocks With A Higher ROI Than Industry Peers at Seeking Alpha |
| 05-Apr-13 10:50AM | ResMed: CMS Takes Rungs Out Of Ladder at Seeking Alpha |
| 03-Apr-13 03:00PM | ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results PR Newswire |
| 02-Apr-13 01:48PM | ResMed Protects Patent Landscape Zacks |
| 28-Mar-13 05:04PM | ResMed takes action with ITC, U.S. federal court to halt patent infringement at theflyonthewall.com |
| 05:00PM | InPlay: ResMed takes action to enforce patents: suit filed against APEX Medical Corp. for patent infringement on devices and masks Briefing.com |
| 04:59PM | ResMed Takes Action to Enforce Patents PR Newswire |
| 25-Mar-13 01:04PM | 5 Stocks Pulling The Health Services Industry Downward at TheStreet |
| 22-Mar-13 10:29AM | Can ResMed Grow Enough To Support Its Premium Valuation? at Seeking Alpha |
| 19-Mar-13 04:48PM | Why I Have Been Buying ResMed Inc. In My Long Term Portofolio at Seeking Alpha |
| 15-Mar-13 11:28AM | Medical Device Companies Outperform Benchmarks Despite European Concerns: Joanne K. Wuensch, Research Analyst at BMO Capital Markets Corp., Interviews with The Wall Street Transcript Wall Street Transcript |
| 13-Mar-13 05:30PM | ResMed Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 01:30 PM at Seeking Alpha |
| 08-Mar-13 09:04AM | Feb. Jobs Data Ignites Futures; U.S. Silica Spikes Before Open at Investor's Business Daily |
| 07-Mar-13 04:21PM | Stocks Close Modestly Higher Ahead Of Jobs Report at Investor's Business Daily |
| 03:30PM | Stocks Hold Modest Gains; U.S. Silica Hits New High at Investor's Business Daily |
| 02:33PM | MGM Resorts Price Target Raised and 4 More Analyst Notes to Read at Wall St. Cheat Sheet |
| 12:04PM | 5 Stocks Pushing The Health Services Industry Lower at TheStreet |
| 04-Mar-13 04:17PM | RESMED INC Files SEC form 8-K/A, Change in Directors or Principal Officers EDGAR Online |
| 01-Mar-13 05:01PM | ResMed Inc. (RMD): Today's Featured Health Services Laggard at TheStreet |
| 28-Feb-13 12:12PM | 5 Stocks Pushing The Health Services Industry Higher at TheStreet |
| 26-Feb-13 06:20PM | ResMed Inc. Presents at Citi 2013 Global Healthcare Conference, Feb-26-2013 10:20 AM at Seeking Alpha |
| 01:35PM | RESMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhi EDGAR Online |
| 22-Feb-13 02:28PM | Another Study for STJ's EnligHTN Zacks |
| 02:08PM | Safeway Ticks Higher on 4Q Results Zacks |
| 21-Feb-13 05:00PM | ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment PR Newswire |
| 20-Feb-13 04:39PM | ResMed Promotes Mick Farrell to Replace Father as CEO at Bloomberg |
| 04:08PM | InPlay: ResMed appoints Michael Farrell as Chief Executive Officer; Robert Douglas appointed President and Chief Operating Officer Briefing.com |
| 04:05PM | ResMed Appoints Michael Farrell as Chief Executive Officer; Robert Douglas Appointed President and Chief Operating Officer PR Newswire |
| 02:28PM | Align Upgraded to Neutral Zacks |
| 02:18PM | BioScrip Reaffirmed at Neutral Zacks |
| 15-Feb-13 01:48PM | Qiagen in Collaboration with Lilly Zacks |
| 12:58PM | Zimmer Stays at Neutral Zacks |
| 12:27PM | The Music Stops For ResMed: Potential Downside, And Management Already Has A Seat at Seeking Alpha |
| 14-Feb-13 08:11AM | The Zacks Analyst Blog Highlights: Cisco Systems, CVS Caremark, ResMed, Medical Action and MedAssets Zacks |
| 13-Feb-13 05:13PM | Thermo Fisher Remains at Neutral Zacks |
| 04:53PM | CVS Broadens Pharmacy Advisor Zacks |
| 01:58PM | Merge Extends Customer Base Zacks |
| 01:38PM | Stryker Hits 52-Week High Zacks |
| 01:18PM | CE Mark for BSX's Promus Premier Zacks |
| 09:59AM | ResMed Stock To Go Ex-dividend Tomorrow (RMD) at TheStreet |
| 12-Feb-13 05:48PM | STJ Presents RESPECT Trial Data Zacks |
| 01:58PM | Still Neutral on Cepheid Zacks |
| 01:48PM | Epocal Acquired by Alere Zacks |
| 12:18PM | Life's Products Gain FDA Approval Zacks |
| 11:29AM | Cash Dividend On The Way From ResMed at Forbes |
| 08:58AM | Smith & Nephew Beats in 4Q Zacks |
| 11-Feb-13 03:09PM | Hospitals' Fiscal Health Ready For Checkup This Week at Investor's Business Daily |
| 08:38AM | Solid 4Q for Conceptus Zacks |
| 01:02AM | How ResMed is Bringing Bucks Home More Quickly at Motley Fool |
| 08-Feb-13 05:58PM | Covidien Issues STAR Trial Data Zacks |
| 02:50PM | Another Challenging Quarter for LH Zacks |
| 01:58PM | Myriad Tops Estimates; Tweaks View Zacks |
| 08:18AM | A Mixed Quarter for Hologic Zacks |
| 08:08AM | Genomic Beats Estimates Zacks |
| 06-Feb-13 12:25PM | All-Front Beat for CVS, Up Y-Y Zacks |
| 09:28AM | MWI Vet Beats with Ease in 1Q13 Zacks |
| 05-Feb-13 04:08PM | DGX Downgraded to Underperform Zacks |
| 03:31PM | Becton Beats Again, Guides High Zacks |
| 01:48PM | Impressive Square Beat for Edwards Zacks |
| 01:04PM | RESMED INC Financials EDGAR Online Financials |
| 09:18AM | LIFE Beats 4Q Rev, Misses EPS Zacks |
| 04-Feb-13 04:18PM | Cardinal Health: Set to Beat Zacks |
| 01-Feb-13 02:08PM | Abaxis Surpasses Estimates in 3Q Zacks |
| 12:08PM | Omnicell Beats with Record Numbers Zacks |
| 09:18AM | Mixed Quarter for Haemonetics Zacks |
| 09:10AM | Don't Get Too Worked Up Over ResMed's Latest Numbers at Motley Fool |
| 31-Jan-13 06:05PM | NYSE stocks posting largest percentage decreases AP -6.49% |
| 01:48PM | Encouraging Square Beat for Align Zacks |
| 01:17PM | NYSE stocks posting largest percentage decreases AP |
| 11:28AM | Solid 4Q for Thermo Fisher Zacks |
| 08:59AM | InPlay: ResMed trading lower by 6% in pre-mkt following release of new medicare payment amounts Briefing.com |
| 06:15AM | RESMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 30-Jan-13 11:47AM | ResMed Stock Still Breathes Easy After 60% Run To New Highs at Forbes |
| 11:28AM | Earnings Preview: CR Bard Inc. Zacks |
|
|
| ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products for the treatment of obstructive sleep apnea and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and data control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors, independent manufacturers, representatives, and direct sales force in approximately 70 countries primarily in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway, and Sweden. ResMed Inc. was founded in 1989 and is based in San Diego, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| QUINN MICHAEL A | Director | May 13 | Sale | 50.94 | 15,000 | 764,130 | 296,000 | May 15 08:07 PM | | Sandercock Brett | Chief Financial Officer | May 08 | Option Exercise | 21.03 | 28,000 | 588,700 | 97,518 | May 10 07:04 PM | | Sandercock Brett | Chief Financial Officer | May 08 | Sale | 48.97 | 28,000 | 1,371,076 | 69,518 | May 10 07:04 PM | | Sandercock Brett | Chief Financial Officer | May 03 | Option Exercise | 21.03 | 23,700 | 498,293 | 93,218 | May 07 08:36 PM | | Sandercock Brett | Chief Financial Officer | May 03 | Sale | 48.01 | 23,700 | 1,137,719 | 69,518 | May 07 08:36 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | May 01 | Option Exercise | 21.03 | 7,500 | 157,688 | 105,831 | May 03 06:10 PM | | Sandercock Brett | Chief Financial Officer | May 01 | Option Exercise | 21.03 | 3,300 | 69,383 | 72,426 | May 03 06:11 PM | | Sandercock Brett | Chief Financial Officer | May 01 | Sale | 48.03 | 3,300 | 158,489 | 69,518 | May 03 06:11 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | May 01 | Sale | 48.00 | 8,000 | 384,000 | 97,981 | May 03 06:10 PM | | SULPIZIO RICHARD | Director | Apr 30 | Option Exercise | 23.10 | 12,000 | 277,140 | 38,527 | May 02 08:10 PM | | FARRELL PETER C | Executive Chairman | Apr 30 | Sale | 47.84 | 78,076 | 3,735,351 | 0 | May 02 08:12 PM | | SULPIZIO RICHARD | Director | Apr 30 | Sale | 47.56 | 12,000 | 570,696 | 26,527 | May 02 08:10 PM | | Reiser Anne | President - ResMed Europe | Apr 29 | Option Exercise | 22.54 | 30,000 | 676,050 | 66,803 | May 01 07:33 PM | | Reiser Anne | President - ResMed Europe | Apr 29 | Sale | 47.25 | 30,000 | 1,417,380 | 36,803 | May 01 07:33 PM | | TAYLOR RONALD R | Director | Apr 29 | Sale | 47.11 | 10,286 | 484,573 | 22,175 | May 01 07:34 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | Apr 01 | Option Exercise | 21.03 | 7,500 | 157,688 | 106,331 | Apr 03 08:47 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | Apr 01 | Sale | 46.19 | 8,000 | 369,558 | 98,331 | Apr 03 08:47 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | Mar 04 | Option Exercise | 21.03 | 7,500 | 157,688 | 106,831 | Mar 05 09:50 PM | | Douglas Robert Andrew | President and COO ResMed Inc. | Mar 04 | Sale | 43.43 | 8,000 | 347,455 | 98,831 | Mar 05 09:50 PM | | ROBERTS CHRISTOPHER G | Director | Feb 27 | Sale | 43.37 | 10,000 | 433,700 | 272,400 | Feb 27 08:37 PM | | ROBERTS CHRISTOPHER G | Director | Feb 26 | Sale | 43.20 | 10,000 | 432,024 | 282,400 | Feb 27 08:37 PM | | Reiser Anne | President - ResMed Europe | Feb 25 | Option Exercise | 24.57 | 10,000 | 245,700 | 46,803 | Feb 27 08:39 PM | | Reiser Anne | President - ResMed Europe | Feb 25 | Sale | 43.20 | 10,000 | 432,000 | 36,803 | Feb 27 08:39 PM | | ROBERTS CHRISTOPHER G | Director | Feb 25 | Sale | 43.12 | 10,000 | 431,200 | 292,400 | Feb 27 08:37 PM | | PENDARVIS DAVID | Chief Administrative Officer | Feb 05 | Sale | 44.40 | 0 | 20 | 65,717 | Feb 07 08:05 PM | | Douglas Robert Andrew | COO ResMed Inc. | Feb 04 | Option Exercise | 21.03 | 7,500 | 157,688 | 107,330 | Feb 06 04:09 PM | | Douglas Robert Andrew | COO ResMed Inc. | Feb 04 | Sale | 44.14 | 8,000 | 353,113 | 99,331 | Feb 06 04:09 PM | | QUINN MICHAEL A | Director | Jan 31 | Option Exercise | 9.80 | 9,000 | 88,182 | 311,000 | Feb 01 07:20 PM | | QUINN MICHAEL A | Director | Jan 30 | Option Exercise | 9.80 | 3,000 | 29,394 | 305,000 | Feb 01 07:20 PM | | FARRELL PETER C | Executive Chairman and CEO | Jan 30 | Option Exercise | 23.10 | 400,000 | 9,238,000 | 1,020,916 | Feb 01 07:21 PM | | FARRELL PETER C | Executive Chairman and CEO | Jan 30 | Sale | 46.98 | 400,000 | 18,790,800 | 620,916 | Feb 01 07:21 PM | | QUINN MICHAEL A | Director | Jan 30 | Sale | 47.75 | 3,000 | 143,250 | 302,000 | Feb 01 07:20 PM | | Farrell Michael J. | President - Americas | Jan 29 | Option Exercise | 21.03 | 8,000 | 168,200 | 94,796 | Jan 31 07:17 PM | | Farrell Michael J. | President - Americas | Jan 29 | Sale | 47.32 | 8,000 | 378,560 | 86,796 | Jan 31 07:17 PM | | WAREHAM JOHN P | Director | Jan 28 | Option Exercise | 15.52 | 36,000 | 558,720 | 49,000 | Jan 30 06:10 PM | | WAREHAM JOHN P | Director | Jan 28 | Sale | 48.20 | 36,000 | 1,735,200 | 13,000 | Jan 30 06:10 PM | | Reiser Anne | President - ResMed Europe | Nov 21 | Option Exercise | 40.72 | 15,715 | 639,915 | 36,293 | Nov 23 03:48 PM | | Darkin Donald | Pres. SDB SBU | Nov 20 | Option Exercise | 15.52 | 30,000 | 465,600 | 50,000 | Nov 21 07:30 PM | | PENDARVIS DAVID | Chief Administrative Officer | Nov 20 | Option Exercise | 15.52 | 6,443 | 99,995 | 65,717 | Nov 21 07:28 PM | | Darkin Donald | Pres. SDB SBU | Nov 20 | Sale | 40.05 | 30,000 | 1,201,410 | 20,000 | Nov 21 07:30 PM | | Sandercock Brett | Chief Financial Officer | Nov 19 | Sale | 40.66 | 30,000 | 1,219,740 | 68,684 | Nov 21 07:29 PM | | PENDARVIS DAVID | Chief Administrative Officer | Nov 16 | Sale | 38.93 | 51,662 | 2,011,357 | 59,274 | Nov 19 08:03 PM | | PENDARVIS DAVID | Chief Administrative Officer | Nov 15 | Sale | 39.00 | 33,640 | 1,311,960 | 110,936 | Nov 19 08:03 PM | | Darkin Donald | Pres. SDB SBU | Nov 14 | Sale | 39.24 | 19,210 | 753,704 | 20,000 | Nov 15 09:19 PM | | Darkin Donald | Pres. SDB SBU | Nov 13 | Option Exercise | 21.68 | 5,000 | 108,375 | 44,210 | Nov 15 09:19 PM | | Darkin Donald | Pres. SDB SBU | Nov 13 | Sale | 39.62 | 5,000 | 198,090 | 39,210 | Nov 15 09:19 PM | | Farrell Michael J. | President - Americas | Nov 01 | Option Exercise | 21.71 | 20,000 | 434,200 | 119,300 | Nov 05 07:54 PM | | Farrell Michael J. | President - Americas | Nov 01 | Sale | 40.80 | 20,000 | 815,940 | 99,300 | Nov 05 07:54 PM | | Sandercock Brett | Chief Financial Officer | Aug 28 | Option Exercise | 23.10 | 25,000 | 577,375 | 123,684 | Aug 30 05:48 PM | | Sandercock Brett | Chief Financial Officer | Aug 28 | Sale | 37.50 | 25,000 | 937,500 | 98,684 | Aug 30 05:48 PM | | WAREHAM JOHN P | Director | Aug 27 | Option Exercise | 21.03 | 18,000 | 378,450 | 31,000 | Aug 29 07:29 PM | | WAREHAM JOHN P | Director | Aug 27 | Sale | 37.34 | 18,000 | 672,138 | 13,000 | Aug 29 07:29 PM | | Sandercock Brett | Chief Financial Officer | Aug 22 | Option Exercise | 23.10 | 25,000 | 577,375 | 77,969 | Aug 24 05:57 PM | | Sandercock Brett | Chief Financial Officer | Aug 22 | Sale | 37.00 | 25,000 | 925,000 | 52,969 | Aug 24 05:57 PM | | Farrell Michael J. | President - Americas | Aug 08 | Option Exercise | 21.71 | 30,000 | 651,300 | 83,410 | Aug 10 06:07 PM | | Farrell Michael J. | President - Americas | Aug 08 | Sale | 35.58 | 30,000 | 1,067,310 | 53,410 | Aug 10 06:07 PM | | WAREHAM JOHN P | Director | Aug 07 | Option Exercise | 21.03 | 18,000 | 378,450 | 19,058 | Aug 08 06:46 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 07 | Option Exercise | 23.10 | 23,333 | 538,876 | 81,557 | Aug 08 06:47 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 07 | Option Exercise | 23.10 | 23,333 | 538,876 | 81,557 | Aug 09 05:38 PM | | PACE GARY W | Director | Aug 07 | Option Exercise | 9.80 | 48,000 | 470,304 | 125,723 | Aug 09 05:40 PM | | PACE GARY W | Director | Aug 07 | Sale | 36.00 | 48,000 | 1,728,000 | 77,273 | Aug 09 05:40 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 07 | Sale | 36.00 | 23,333 | 839,988 | 58,224 | Aug 09 05:38 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 07 | Sale | 36.00 | 23,333 | 839,988 | 58,224 | Aug 08 06:47 PM | | WAREHAM JOHN P | Director | Aug 07 | Sale | 35.99 | 15,000 | 539,899 | 10,000 | Aug 08 06:46 PM | | WAREHAM JOHN P | Director | Aug 06 | Option Exercise | 23.10 | 12,000 | 277,140 | 22,000 | Aug 08 06:46 PM | | WAREHAM JOHN P | Director | Aug 06 | Sale | 35.74 | 12,000 | 428,825 | 10,000 | Aug 08 06:46 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 03 | Option Exercise | 23.10 | 46,667 | 1,077,774 | 81,024 | Aug 07 08:04 PM | | Douglas Robert Andrew | COO ResMed Inc. | Aug 03 | Sale | 34.82 | 46,667 | 1,624,945 | 57,691 | Aug 07 08:04 PM | | ROBERTS CHRISTOPHER G | Director | Jul 06 | Option Exercise | 6.36 | 30,000 | 190,650 | 30,000 | Jul 10 08:20 PM |
|
|
|
|
|
|
